Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

BAKER HEART AND DIABETES INSTITUTE

Home Clinical Trial Sponsors and OrganizationsBAKER HEART AND DIABETES INSTITUTE

BAKER HEART AND DIABETES INSTITUTE

75 Commercial Rd, Melbourne, Victoria, Australiawww.bakeru.edu481 employeesEstablished: 1858-01-01

Also known as:

diabesity australia

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

55

16 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

1858

Overview

Trial Phase Distribution

Phase

Trials

Share

Not Applicable

23

41.8%

Phase 4

16

29.1%

Unknown

4

7.3%

Phase 1

1

1.8%

Phase 2

1

1.8%

Trial Status Distribution

Active, not recruiting

3

5.5%

Completed

15

27.3%

Not yet recruiting

13

23.6%

Recruiting

14

25.4%

Terminated

4

7.3%

Unknown

3

5.5%

Withdrawn

3

5.5%

Clinical Trials

Trials sponsored by this organization (55)

Remote Monitoring for Patients With Aortic Stenosis

Not yet recruiting

Sep 2026160 participants

Fat Incorporation through omega-3 Supplementation to determine immune cellular changes

Active, not recruiting

Sep 202660 participants

A two-step screening pathway to detect early heart failure in cancer survivors: the TRIAGE-HF pilot study

Active, not recruiting

Jul 2026150 participants

Exercise to Improve Neurovascular Function in Breast Cancer Survivors

Not yet recruiting

Nov 202540 participants

Echo Acquisition Despite Geographic Separation by Replication of Human Movements (EAGER)

Not yet recruiting

Jan 202550 participants

Reducing Cognitive Impairment by Management of Heart Failure as a Modifiable Risk Factor

Jul 2024168 participants

Safety and efficacy of the Android Artificial System (AAPS) with advanced bolus-free features in Adults with Type 1 diabetes with extended use.(Close It Extended)

Not yet recruiting

May 202438 participants

Stepping towards precision rehabilitation; Establishing potential benefits and safety of early cardiac rehabilitation in diabetics post acute coronary syndrome

Not yet recruiting

Apr 202470 participants

Page 1 of 7

Approvals

No approval data available

News

Glucotrack Secures Ethical Approval for Long-Term Clinical Study of Implantable Blood Glucose Monitor

- Glucotrack has received ethical approval from St. Vincent's Hospital Melbourne HREC for a year-long clinical study of its implantable continuous blood glucose monitor in patients with type 1 and type 2 diabetes. - The multi-center study will enroll up to 30 participants requiring intensive insulin therapy, with first implantations expected by July 2025 and potential extension to three years of monitoring. - Unlike traditional CGMs that measure glucose in interstitial fluid, Glucotrack's device directly measures blood glucose with no wearable component and is designed to function for up to three years.

On this page

Overview
Clinical Trials55
Approvals
News1

Back to Organizations